Mark Plavsic, Chief Technology Officer at Aura Biosciences, Inc. (AURA), sold 14,766 shares at $9.85 ($145K) on 2024-10-16, disclosed to the SEC on 2024-10-16.
Open-market sale of $145k AURA by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.85 | 7,383 | $73K | 50.0% |
| 2 | $9.85 | 7,383 | $73K | 50.0% |
| Total | $9.85 avg | 14,766 | $145K | 100% |
| Filing → |
| AURA | SELL | 2025-02-18 | $17K | — | Filing → |
| FATE | SELL | 2023-01-11 | $18K | — | Filing → |
| FATE | SELL | 2022-07-06 | $183K | — | Filing → |